京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第21624号 / 医博第4430号 / 新制||医||1033(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 川口 義弥, 教授 福田 和彦, 教授 坂井 義治 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

No description available.

Interest in, and rates of, wetland restoration have increased over the past several decades. However, despite proliferations of restored wetlands across the landscape, the structural and functional restoration success of these systems is unclear. Thus, understanding factors and processes that influence wetland characteristics is of considerable interest. This study focuses on herbaceous wetlands in the Mississippi River Alluvial Valley (MAV), a largely agricultural region interspersed with restored and naturally occurring wetlands. Chapter I is an introduction and provides a background to wetlands, wetland ecology, and the current state of wetland restoration in the United States. Chapter II focuses on factors which affect seedling density and similarities between standing vegetation, germinated seedlings, and early successional stage assemblages. Seedling density was heavily influenced by hydrology while richness and diversity were similar between restored and non-managed wetlands. Landscape-level factors affected seedling density, while germinated seedlings did not reflect standing vegetation in MAV wetlands. In Chapter III, I examine the impact of agricultural stressors on wetland plant assemblage development. Resulting assemblages showed strong fidelity to wetland soil site of origin while richness and diversity were negatively affected by elevated stressor levels. In Chapter IV, I compare characteristics between non-managed and restored wetlands in the MAV. These wetlands differed hydrologically, had different levels of soil organic matter, were dissimilar in plant assemblage composition, and varied by surrounding land use/cover. Finally, Chapter V is a discussion of the results and places this work within a larger context.

Government of Sri Lanka has policy target to achieve 100% electrification by end of year 2012. Grid-based electrification is possible up to maximum 95% of the population in Sri Lanka. Balance 5% of the electrification has to be mainly depending on off-grid technologies such as solar PV, wind, biomass and micro hydro.   Use of renewable based off-grid technologies is limited by the seasonal variation of the resource. This barrier could be overcome by coupling renewable based power generation technologies with a diesel generation thereby forming a hybrid power system. Given the comparatively higher investment cost, a hybrid power plant needs to be carefully designed and optimized to generate electricity at competitive prices.   There are some Isolated Islands located in the Jaffna Peninsula (Northern part of Sri Lanka) called Eluvaithivu, Analaithivu, Nainathivu and Delft Islands. These islands are far away from mainland. At present diesel generators are supplying electricity to these islands for limited hours. Electrification rate of these islands are very low due to the Grid limitations. Also cost of electricity generation is very high due to the high diesel price.   The main objective of the present study is “Selection of optimized mix of renewable based power generation technologies to form a mini-grid and to supply reliable, cost effective electricity supply to the people living in Eluvaithivu Island’ and thereby support the 100% electrification target by Govt. of Sri Lanka in 2012.   Data collection, survey has been conducted in the Eluvaithivu Island to find out the status of present system, priority needs, resource data and load data to propose suitable power system for this Island. An extensive analyse was conducted using HOMER software model and the result is presented in the report. Optimum design emerges as a wind-diesel hybrid power system having wind turbines generator, diesel generators, battery bank, converter and a hybrid controller.   The result revealed that the economic viability of the project, in the form of a community owned wind-diesel hybrid power system operated on cost-recovery basis is not feasible. But it is an attractive option for CEB to reduce its long term losses on diesel fuel. In other words, if CEB implement this project, it would be an ideal win-win situation where both the CEB and the island community are benefited.

この論文では従来電力系統から自立的に利用出来る太陽エネルギー及び燃料電池コジェネレーションシステムの徹底的な解析が述べられている。開発した水素マイクログリッドの燃料依存を最小化にする数理モデルを利用し日本社会でのさまざまなシナリオのシミュレーションが行なわれた。こういうシステムの実現性が従来水素燃料供給方法の審査及び日本の中型離島の事例研究で評価された。経済的な分析によって石油の価格が高い遠隔な地域では水素マイクログリッドは競争力があると分かった。 / This thesis presents a thorough analysis on energy supply systems using solar energy and fuel cell cogeneration systems that can operate reliably and independently from the main power grid. A mathematical model to maximize fuel independence for hydrogen micro-grids is developed and simulated for various scenarios in Japanese communities. The viability of implementing such systems is assessed with a review of available hydrogen supply channels, and a study case for a remote Japanese island of medium size. An economic analysis of this study suggests that hydrogen micro-grids are economically competitive for energy supply in remote areas where oil prices are high. / 博士(工学) / Doctor of Philosophy in Engineering / 同志社大学 / Doshisha University

Objective: The aim was to determine if in vitro ischaemic preincubation can precondition cardiomyocytes and if the responses to adenosine receptor antagonists are similar to those previously determined during 'metabolic' preconditioning with glucose deprivation or adenosine agonists. Methods: Isolated rabbit cardiomyocytes were preconditioned with 10 min of ischaemic preincubation, followed by a 30 min postincubation before the final sustained ischaemic period. The protein kinase C inhibitor calphostin C or the adenosine receptor antagonists 8-sulphophenyltheophylline (SPT), BW 1433U, and 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) were added either during the preincubation or into the final ischaemic pellet. Adenosine deaminase (10 U·ml-1) was added during ischaemic preincubation. Rates of contracture and extent of injury were determined by sequential sampling and assessment of trypan blue permeability following 85 mOsM swelling. Results: Myocytes were preconditioned by a 10 min in vitro ischaemic preincubation. Preincubation with 100 μM SPT or with adenosine deaminase, or addition of 200 nM calphostin C into the final ischaemic pellet did not alter rates of rigor contracture but nearly abolished protection. A significant degree of protection was maintained following ischaemic preincubation with the highly selective adenosine A1 receptor blocker DPCPX (10 μM), while the A1/A3 antagonist BW 1433U (1 μM) severely limited protection. SPT and BW 1433U added only into the final ischaemic pellet of preconditioned cells significantly blocked protection, while protection was maintained in the presence of DPCPX. Conclusions: Ischaemic preconditioning of cardiomyocytes is blocked by adenosine receptor antagonists known to bind to A3 receptors but not by DPCPX which has high affinity for A1 receptors, but little affinity for A3 receptors. Maintenance of protection during the final ischaemic phase has a similar receptor specificity. Blockade of protein kinase C activity abolishes protection. Ischaemic and metabolic preconditioning in vitro appear to occur through similar pathways.

Objective: The aim was to determine if in vitro ischaemic preincubation can precondition cardiomyocytes and if the responses to adenosine receptor antagonists are similar to those previously determined during "metabolic" preconditioning with glucose deprivation or adenosine agonists. Methods: Isolated rabbit cardiomyocytes were preconditioned with 10 min of ischaemic preincubation, followed by a 30 min postincubation before the final sustained ischaemic period. The protein kinase C inhibitor calphostin C or the adenosine receptor antagonists 8-sulphophenyltheophylline (SPT), BW 1433U, and 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) were added either during the preincubation or into the final ischaemic pellet. Adenosine deaminase (10 U · ml-1) was added during ischaemic preincubation. Rates of contracture and extent of injury were determined by sequential sampling and assessment of trypan blue permeability following 85 mOsM swelling. Results: Myocytes were preconditioned by a 10 min in vitro ischaemic preincubation. Preincubation with 100 μM SPT or with adenosine deaminase, or addition of 200 nM calphostin C into the final ischaemic pellet did not alter rates of rigor contracture but nearly abolished protection. A significant degree of protection was maintained following ischaemic preincubation with the highly selective adenosine A1 receptor blocker DPCPX (10 μM), while the antagonist BW 1433U (1 μM) severely limited protection. SPT and BW 1433U added only into the final ischaemic pellet of preconditioned cells significantly blocked protection, while protection was maintained in the presence of DPCPX. Conclusions: Ischaemic preconditioning of cardiomyocytes is blocked by adenosine receptor antagonists known to bind to A3 receptors but not by DPCPX which has high affinity for A1 receptors, but little affinity for A3 receptors. Maintenance of protection during the final ischaemic phase has a similar receptor specificity. Blockade of protein kinase C activity abolishes protection. Ischaemic and metabolic preconditioning in vitro appear to occur through similar pathways.

Objective: The aim was to further characterise an experimental model of preconditioning of isolated rabbit cardiomyocytes and to determine the role of adenosine receptor subtypes in initiation of the protective response. Methods: Isolated myocytes were subjected to 5 min preincubation in the presence or absence of glucose and various agonists and antagonists of adenosine receptors. Ischaemic pelleting was preceded by a 30 min postincubation period. Rate and extent of injury during ischaemia was determined by sequential sampling of the pelleted cells and assessment of trypan blue permeability following 85 mOsm swelling. Results: Myocytes were preconditioned with a 30-50% reduction of injury by a 5 min glucose-free preincubation. Substitution of 5 mM pyruvate for glucose during preincubation did not prevent the protective response. Protection was maintained over a 60-180 min postincubation period. Protection was blocked by 100 μM of the non-specific adenosine A1A2, antagonist SPT, both when added only during preincubation or only into the ischaemic pellet. Calphostin C, a specific protein kinase C inhibitor at 200 nM, added to the ischaemic pellet blocked protection. Preincubation with R-PIA, the adenosine A1 agonist, did not precondition at an A1 selective dose of 1 μM, but did at 100 μM. The selective A2 agonist CGS 12680 (1 μM) did not precondition. The selective A1/A3 adenosine agonist, APNEA, preconditioned at 1 μM and 200 nM dose levels. Preconditioning induced either by 200 nM APNEA or by glucose-free preincubation was not blocked by 200 nM or 10 μM of the A1 antagonist DPCPX, which has extremely low affinity for A3 receptors, but was blocked by 1 μM of the A1/A3 adenosine antagonist BW 1433U83. Conclusions: Preconditioning can be induced in isolated myocytes by a 5 min preincubation/30 min postincubation protocol, and a similar protection induced by adenosine agonists with A3, but not A1 selectivity. Preconditioning is blocked by non-selective or selective A1/A3 adenosine antagonists and a specific protein kinase C inhibitor, but not by A1 antagonists with little affinity for A3 receptors. The results suggest that preconditioning in isolated rabbit myocytes requires participation of adenosine receptors with agonist/antagonist binding characteristics of the A3 subtype, and is likely to be mediated by activation of protein kinase C.Cardiovascular Research 1994;28:1049-1056.

Objective: The aim was to discriminate among several hypotheses of preconditioning of isolated rabbit cardiomyocytes and to determine if ischaemic preincubation would evoke a protective response. Methods: Isolated myocytes were subjected to 5 min of preincubation, in the presence or absence of glucose, and incubated in the presence of 1 mM iodoacetic acid during the final sustained ischaemic period. In a second series, the protein kinase C (PKC) activators phorbol 12-myristate 13-acetate (PMA), ingenol 3, 20-dibenzoate, and thymeleatoxin were added during preincubation. In a third series, preincubation periods were substituted by brief ischaemic pelleting of cells. Final prolonged ischaemic pelleting was preceded by a 30 min postincubation period. Rate and extent of injury was determined by sequential sampling and assessment of trypan blue permeability following 85 mOsM swelling. Results: Myocytes were preconditioned by a 5 min glucose-free preincubation. Addition of iodoacetic acid into the final ischaemic pellet increased the rates of rigor contracture and injury, but did not abolish the protective response. Direct protein kinase C activation with PMA, a non-selective phorbol ester, and ingenol, an ε, δ-PKC isozyme selective activator, protected cells, but thymeleatoxin, an α,β,γ-PKC isozyme selective activator, did not. A 10 min ischaemic preincubation preconditioned, but the protection was not enhanced when ischaemia was extended to 30 min, or when PMA was included during the initial ischaemic preincubation. Adenosine partially inhibited the response. Conclusions: (1) Preconditioning of isolated myocytes is not dependent on glycolysis or glucose transport. (2) Preconditioning appears dependent on activation of the ε-PKC isoformn. (3) Ischaemia is capable of preconditioning isolated myocytes in vitro, and initiation of this effect is modified by simultaneous additional of adenosine but not by direct protein kinase C activation with PMA. Induction of protection by PMA and ingenol shows that protection requires protein kinase C activation, but direct potassium channel activation by regulatory G proteins is not critical.Cardiovascular Research 1994;28:1700-1706.

Calcium-tolerant rabbit cardiomyocytes were isolated using retrograde aortic perfusion with a nominally calcium-free, collagenase buffer. In vitro ischemic preconditioning was induced by a 10-min episode of ischemic pelleting, followed by a 15-min post-incubation and a prolonged period of ischemic pelleting. Injury was assessed by determination of cell contracture and trypan blue permeability following hypotonic swelling and correlated with metabolic assays of lactate and adenine nucleotides. The protein phosphatase PP1/2A inhibitor calyculin A and PP2A-selective fostriecin protected isolated rabbit cardiomyocytes from lethal injury after a 10-min pre-incubation and when added late into ischemic pellets after a delay of 75 min. At the time of late drug addition, cells were severely ATP-depleted and in rigor contracture. Protection with Calyculin A from 1 nM to 1 μM was dose-related. Cells pre-incubated with 10 nM to 10 μM fostriecin 10 min prior to ischemic pelleting were protected with an EC50 approximating 71 nM, implying protection at a PP2A-selective dose. The selective protein kinase C inhibitor, calphostin C, blocked ischemic preconditioning protection but not protection from 1 μM calyculin A. Protection of severely ischemic cardiomyocytes following protein phosphatase inhibition appears not to require PKC activity or ATP conservation. Pre-incubation of cells with calyculin A induced high levels of phosphorylation in p38 mitogen activated protein kinase (MAPK), as compared to the ischemia-induced phosphorylation observed in the untreated group only at 30 min of ischemia, providing evidence of protein phosphatase activity in cardiomyocytes. Pharmacological protection in late ischemia has been demonstrated, but the mechanism of protection is undetermined.